Oral Oncology
Volume 37, Issue 7 , Pages 553-557 , October 2001

Expression of p53 in oral squamous cell carcinoma and its association with risk habits in southern Thailand

  • Duangporn Kerdpon

      Affiliations

    • Department of Stomatology, Faculty of Dentistry, Prince of Songkla University, Haad Yai, Songkhla 90112, Thailand
    • Corresponding Author InformationCorresponding author. Tel.: +66-74-429878; fax: +66-74-212922
    • ,
  • Hutcha Sriplung

      Affiliations

    • Department of Pathology, Faculty of Medicine, Prince of Songkla University, Haad Yai, Songkhla 90112, Thailand
    • ,
  • Suparp Kietthubthew

      Affiliations

    • Department of Stomatology, Faculty of Dentistry, Prince of Songkla University, Haad Yai, Songkhla 90112, Thailand

Received 7 August 2000 ,Accepted 26 August 2000.

References 

  1. Kerdpon D, Rich AM, Reade PC. Expression of p53 in oral mucosal hyperplasia, dysplasia and squamous cell carcinoma. Oral Dis. 1997;3(2):86–92
  2. Kaur J, Srivastava A, Ralhan R. Overexpression of p53 protein in betel-and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int J Cancer. 1994;58(3):340–345
  3. Kuttan NA, Rosin MP, Ambika K, Priddy RW, Bhakthan NM, Zhang L. High prevalence of expression of p53 oncoprotein in oral carcinomas from India associated with betel and tobacco chewing. Eur J Cancer B Oral Oncol. 1995;31B(3):169–173
  4. Ranasinghe AW, Warnakulasuriya KAAS, Johnson NW. Low prevalence of expression of p53 oncoprotein in oral carcinomas from Sri Lanka associated with betel and tobacco chewing. Eur J Cancer B Oral Oncol. 1993;29B(2):147–150
  5. Wong YK, Liu TY, Chang KW, Lin SC, Chao TW, Li PU, et al.  p53 alterations in betel quid- and tobacco-associated oral squamous cell carcinomas from Taiwan. J Oral Pathol Med. 1998;27(6):243–248
  6. Brennan JA, Boyle JO, Koch WM, Goodman SN, Hruban RH, Eby YJ, et al.  Association between cigarette smoking and mutation of the p53 gene in squamous-cell carcinoma of the head and neck. N Eng J Med. 1995;332(16):712–717
  7. Boyle JO, Hakim J, Koch W, van der Riet P, Hruban RH, Roa RA, et al.  The incidence of p53 mutations increased with progression of head and neck cancer. Cancer Res. 1993;53(19):4477–4480
  8. Ranasinghe A, MacGeoch C, Dyer S, Spurr N, Johnson NW. Some oral carcinomas from Sri Lankan betel/tobacco chewers overexpressed p53 oncoprotein but lack mutations in axon 5–9. Anticancer Res. 1993;13(6A):2065–2068
  9. Thomas S, Brennan J, Martel G, Frazer I, Montesano R, Sidransky D, et al.  Mutations in the conserved regions of p53 are infrequent in betel-associated oral cancers from Papua New Guinea. Cancer Res. 1994;54(13):3588–3593
  10. Yan JJ, Tzeng CC, Jin YT. Overexpression of p53 protein in squamous cell carcinoma of buccal mucosa and tongue in Taiwan: an immunohistochemical and clinicopathological study. J Oral Pathol Med. 1996;25(2):55–59
  11. Chiang CP, Huang JS, Wang JT, Liu BY, Kuo YS, Hahn LJ, et al.  Expression of p53 protein correlates with decreased survival in patient with areca quid chewing and smoking-associated oral squamous cell carcinomas in Taiwan. J Oral Pathol Med. 1999;28(2):72–76
  12. Saranath D, Tandle AT, Teni TR, Dedhia PM, Borges AM, Parikh D, et al.  p53 inactivation in chewing tobacco-induced oral cancers and leukoplakias from india. Oral Oncol. 1999;35(3):242–250
  13. Vatanasapt V, Sriamporn S. Oral Cavity. In: Deenasamee S, Martin N, Sontipong S, Sriamporn S, Stiplung H, Srivatanakul P, editiors. Cancer in Thailand Vol. II, 1992–1994. IARC. Technical Report No. 34. Lyon: IARC, 1999 p. 26–9.
  14. World Health Organization, International Classification of Diseases for Oncology, 2nd ed. Geneva: WHO, 1990.
  15. International Union Against Cancer . TNM classification of malignant tumours. 4th ed. Berlin: Springer-Verlag; 1987;
  16. Field JK, Zoumpourlis V, Spandidos DA, Jones AS. p53 expression and mutations in squamous cell carcinoma of the head and neck: expression correlates with the patients' use of tobacco and alcohol. Cancer Detect Prev. 1994;18(3):197–208
  17. Shin DM, Kim J, Ro JY, Hittelman J, Roth JA, Hong WK, et al.  Activation of p53 gene expression in premalignant lesions during head and neck tumorigenesis. Cancer Res. 1994;54(2):321–326
  18. Matthews JB, Scully C, Jovanovic A, Van der Waal I, Yeudall WA, Prime SS. Relationship of tobacco/alcohol use to p53 expression in patients with lingual squamous cell carinoma. Eur J Cancer B Oral Oncol. 1993;29B(4):285–289
  19. van Oijen MG, van de Craats JG, Slootweg PJ. p53 overexpression in oral mucosa in relation to smoking. J Pathol. 1999;187(4):469–474
  20. Trivedy C, Warnakulasuriya KA, Tavassoli M, Steingrimsdottir H, Penhallow J, Maher R, et al.  p53 aberrations in oral submucous fibrosis and oral squamous cell carcinoma detected by immunocytochemistry and PCR-SSCP. J Oral Pathol Med. 1998;27(2):72–77
  21. Werness BA, Levine AJ, Howley DM. Association of human papillomavirus type 16 and 18 E6 protein with p53. Science. 1990;248(4591):76–79
  22. Hubbert NL, Sedman SA, Schiller JT. Human papilloma virus type 16 E6 increased the degradation rate of p53 in human keratinocytes. J Virol. 1992;66(10):6237–6241
  23. Lin J, Teresky AK, Levine AJ. Two critical hydrophobic amino acids in the N-terminal domain of the p53 protein are required for the gain of function phenotypes of human p53 mutants. Oncogene. 1995;10(12):2387–2390
  24. Kubbutat MH, Jones SN, Vousden KH. Regulation of p53 stability by Mdm2. Nature. 1997;387(6630):299–303
  25. Rowley H, Helliwell TR, Jones AS, Roland NJ, Field EA, Field JK. An immunohistochemical analysis of p53 protein expression in pre-malignant and malignant tissue of the oral cavity. Clin Otolaryngol. 1997;22(1):23–29
  26. Ng IO, Lam KY, Ng M, Regezi JA. Expression of p21/waf1 in oral squamous cell carcinomas-correlation with p53 and mdm2 and cellular proliferation index. Oral Oncol. 1999;35(1):63–69
  27. Girod SC, Pfeiffer P, Ries J, Page HD. Proliferative activity and loss of function of tumour suppressor genes as “biomarkers” in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma. Br J Oral Maxillofac Surg. 1998;36(4):252–260
  28. Yao L, Iwai M, Furuta I. Correlations of bcl-2 and p53 expression with the clinicopathological features in tongue squamous cell carcinomas. Oral Oncol. 1999;35(1):56–62
  29. Barel R, Patnik S, Das BR. Co-overexpression of p53 and c-myc proteins linked with advanced stage of betel- and tobacco-related oral squamous cell carcinomas from eastern India. Eur J Oral Sci. 1998;106(5):907–913

PII: S1368-8375(00)00120-2

Oral Oncology
Volume 37, Issue 7 , Pages 553-557 , October 2001

Article Tools

* Image Usage & Resolution